- Potential benefitStrengthens donor consent and disposition protections with required documentation and return obligations.
- Potential benefitImproves biosafety and reduces contamination risks through mandated labeling and packaging standards.
- Potential benefitIncreases transparency via comprehensive recordkeeping and registrant identification for regulators and purchasers.
Consensual Donation and Research Integrity Act of 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
The bill creates a new federal registration and regulatory regime for persons who acquire and sell for profit whole human bodies or human body parts for education, research, or mortuary science (not for transplantation). It requires registration, inspections, recordkeeping (including donor consent documentation and chain-of-custody), labeling and packaging standards, limits on disclosure of identifiable donor information, disposition obligations, fees, and penalties for violations.
Federal registration and inspections versus state regulatory primacy
Relative to its intended legislative type, this bill constitutes a clear substantive regulatory change that creates a framework for registration, recordkeeping, labeling, inspection, disposition, and enforcement for the interstate commercial acquisition and sale of whole human bodies and body parts not intended for transplantation.
The bill creates a new federal registration and regulatory regime for persons who acquire and sell for profit whole human bodies or human body parts for education, research, or mortuary science (not for transplantation).
It requires registration, inspections, recordkeeping (including donor consent documentation and chain-of-custody), labeling and packaging standards, limits on disclosure of identifiable donor information, disposition obligations, fees, and penalties for violations.
Certain entities are exempted, and the law applies two years after enactment.
Narrow regulatory reform with limited ideological salience and built‑in compromise features increases plausibility; legal, privacy, and state‑law interactions create uncertainty.
Relative to its intended legislative type, this bill constitutes a clear substantive regulatory change that creates a framework for registration, recordkeeping, labeling, inspection, disposition, and enforcement for the interstate commercial acquisition and sale of whole human bodies and body parts not intended for transplantation. It provides enumerated statutory requirements while delegating technical standards and operational details to executive regulation.
Federal registration and inspections versus state regulatory primacy
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenImposes new compliance costs and recurring fees on commercial body and body-part sellers.
- Potential burdenCould reduce availability of donated bodies for education and research due to added administrative burdens.
- Potential burdenRequires labeling that may reveal donor identities or medical information, raising privacy concerns.
Why the argument around this bill splits.
Federal registration and inspections versus state regulatory primacy
Likely broadly supportive because the bill strengthens donor consent, privacy, and respectful disposition requirements.
They would welcome chain-of-custody, labeling, and penalties for falsification but watch for enforcement strength and effects on research access.
Generally supportive of transparency, safety, and uniform standards across interstate commerce, while cautious about regulatory duplication and implementation costs.
Would seek clear rules on federal-state interaction and predictable fees and timelines.
Mixed reaction: supportive of protecting donors and criminalizing fraud, but skeptical of new federal registration, fee authority, and potential federal overreach into state-regulated mortuary practices.
Concerned about costs and regulatory burden on commerce.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow regulatory reform with limited ideological salience and built‑in compromise features increases plausibility; legal, privacy, and state‑law interactions create uncertainty.
- No cost estimate or CBO score included
- Possible conflicts with HIPAA and state death‑disposition statutes
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Federal registration and inspections versus state regulatory primacy
Narrow regulatory reform with limited ideological salience and built‑in compromise features increases plausibility; legal, privacy, and sta…
Relative to its intended legislative type, this bill constitutes a clear substantive regulatory change that creates a framework for registration, recordkeeping, labeling, inspection, disposition, and enforcement for the…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.